Breaking News2 years ago
Sotorasib shows clinically meaningful activity in KRAS G12C-mutated advanced pancreatic cancer
[ad_1] Newswise — In the Phase I/II CodeBreaK 100 trial, the KRAS G12C inhibitor sotorasib achieved meaningful anticancer activity with an acceptable safety profile in heavily...
